Studies of Antipsychotic drugs as potential schizophrenia agents
ABSTRACT:
To study describe the actions of antipsychotics or
neuroleptics on the behavioral effects elicited by ketamine on open-field, rota
rod and tail suspension tests in mice. A series of novel analogs of
2-[3-{4-(3-chlorophenyl)-1-piperazinyl} propyl]-1,2,4-triazolo [4,3-a] pyridine-3-
(2H)-one hydrochloride, a potential psychoactive drug of the piperazine and
triazolopyridine chemical classes that has antidepressant, anxiolytic, and
hypnotic properties were synthesized. Male swiss albino mice (25–30g) were used
for the study and compounds were administered alone (0.1 or 0.2 mg/kg) or
thirty minutes before ketamine (10 mg/Kg, ip). ketamine increased (63.3 ± 4.2)
the locomotor activity compared to control, while neuroleptics decreased it
(25.5 ± 4.2). Pretreatment with neuroleptics, in both doses, blocked
hyperlocomotion caused by ketmine.
Further details @
http://www.jocpr.com/
For more details @
http://www.jocpr.com/articles/studies-of-antipsychotic-drugs-as-potential-schizophrenia-agents.pdf
Comments
Post a Comment